America in Transition Pages

Wednesday, February 3, 2016

FDA Advisors Support New Indication for Brintellix

(MedPage Today) -- Panel debates vortioxetine for treating cognitive dysfunction in major depression

from MedPage Today Washington Watch http://ift.tt/1nHG2Kc
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)